These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22272148)

  • 1. Introducing catastrophe-QSAR. Application on modeling molecular mechanisms of pyridinone derivative-type HIV non-nucleoside reverse transcriptase inhibitors.
    Putz MV; Lazea M; Putz AM; Duda-Seiman C
    Int J Mol Sci; 2011; 12(12):9533-69. PubMed ID: 22272148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR study on pyridinone derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitor: a mixed approach.
    Vasanthanathan P; Lakshmi M; Rao AR
    Med Chem; 2007 May; 3(3):227-32. PubMed ID: 17504193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANN QSAR workflow for predicting the inhibition of HIV-1 reverse transcriptase by pyridinone non-nucleoside derivatives.
    Barzegar A; Zamani-Gharehchamani E; Kadkhodaie-Ilkhchi A
    Future Med Chem; 2017 Jul; 9(11):1175-1191. PubMed ID: 28722475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure-activity relationship analysis of pyridinone HIV-1 reverse transcriptase inhibitors using the k nearest neighbor method and QSAR-based database mining.
    Medina-Franco JL; Golbraikh A; Oloff S; Castillo R; Tropsha A
    J Comput Aided Mol Des; 2005 Apr; 19(4):229-42. PubMed ID: 16163450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase.
    Medina-Franco JL; Rodríguez-Morales S; Juárez-Gordiano C; Hernández-Campos A; Jiménez-Barbero J; Castillo R
    Bioorg Med Chem; 2004 Dec; 12(23):6085-95. PubMed ID: 15519154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docking, molecular dynamics and quantitative structure-activity relationship studies for HEPTs and DABOs as HIV-1 reverse transcriptase inhibitors.
    Mao Y; Li Y; Hao M; Zhang S; Ai C
    J Mol Model; 2012 May; 18(5):2185-98. PubMed ID: 21947448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking and 3D-QSAR studies on triazolinone and pyridazinone, non-nucleoside inhibitor of HIV-1 reverse transcriptase.
    Sivan SK; Manga V
    J Mol Model; 2010 Jun; 16(6):1169-78. PubMed ID: 20013136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust Modeling and Scaffold Hopping: Case Study Based on HIV Reverse Transcriptase Inhibitors Type-1 Data.
    Pillai GG; Mederos L; Panda CS; Gronski A; Burk P; Hall CD; Katritzky AR; Tämm K; Karelson M
    Med Chem; 2016; 12(6):513-26. PubMed ID: 26434799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking-based CoMFA and CoMSIA studies of non-nucleoside reverse transcriptase inhibitors of the pyridinone derivative type.
    Medina-Franco JL; Rodríguez-Morales S; Juárez-Gordiano C; Hernández-Campos A; Castillo R
    J Comput Aided Mol Des; 2004 May; 18(5):345-60. PubMed ID: 15595461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hologram quantitative structure-activity relationships investigations of non-nucleoside reverse transcriptase inhibitors.
    Pungpo P; Hannongbua S; Wolschann P
    Curr Med Chem; 2003 Sep; 10(17):1661-77. PubMed ID: 12871115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR study of PETT derivatives as potent HIV-1 reverse transcriptase inhibitors.
    Sabet R; Fassihi A; Moeinifard B
    J Mol Graph Model; 2009 Sep; 28(2):146-55. PubMed ID: 19570701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridin-2(1H)-ones: a promising class of HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Medina-Franco JL; Martínez-Mayorga K; Juárez-Gordiano C; Castillo R
    ChemMedChem; 2007 Aug; 2(8):1141-7. PubMed ID: 17477343
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical structure and correlation analysis of HIV-1 NNRT and NRT inhibitors and database-curated, published inhibition constants with chemical structure in diverse datasets.
    Viira B; García-Sosa AT; Maran U
    J Mol Graph Model; 2017 Sep; 76():205-223. PubMed ID: 28738270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2D and 3D QSAR studies of diarylpyrimidine HIV-1 reverse transcriptase inhibitors.
    Rebehmed J; Barbault F; Teixeira C; Maurel F
    J Comput Aided Mol Des; 2008 Nov; 22(11):831-41. PubMed ID: 18506577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.
    Dufour E; El Dirani-Diab R; Boulmé F; Fournier M; Nevinsky G; Tarrago-Litvak L; Litvak S; Andreola ML
    Eur J Biochem; 1998 Jan; 251(1-2):487-95. PubMed ID: 9492322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Structure-based Methods to Analyze Resistance Mutations for Chemically Diverse Non-Nucleoside Reverse Transcriptase Inhibitors.
    Tabassum T; Azeem SM; Muwonge AN; Frey KM
    Curr HIV Res; 2020; 18(4):283-291. PubMed ID: 32493197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable selection based QSAR modeling on Bisphenylbenzimidazole as Inhibitor of HIV-1 reverse transcriptase.
    Kumar S; Tiwari M
    Med Chem; 2013 Nov; 9(7):955-67. PubMed ID: 23106285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Duchowicz PR; Fernández M; Caballero J; Castro EA; Fernández FM
    Bioorg Med Chem; 2006 Sep; 14(17):5876-89. PubMed ID: 16766190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives.
    Ragno R; Artico M; De Martino G; La Regina G; Coluccia A; Di Pasquali A; Silvestri R
    J Med Chem; 2005 Jan; 48(1):213-23. PubMed ID: 15634015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.
    Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM
    Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.